Study of biochemical predictors of bone loss and bone mineral density in postmenopausal women
Measurement of bone remodelling biomarkers combined with assessing bone mineral density (BMD) helps in identification of postmenopausal women at increased risk of recurrent fractures and in monitoring therapeutic efficacy.
Objective: To assess BMD using ultrasound based regional bone densitometry and to determine the levels of serum markers of bone turnover in postmenopausal women.